Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
- PMID: 12502499
- DOI: 10.2337/diabetes.52.1.102
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
Abstract
Type 2 diabetes is characterized by impaired insulin secretion. Some but not all studies suggest that a decrease in beta-cell mass contributes to this. We examined pancreatic tissue from 124 autopsies: 91 obese cases (BMI >27 kg/m(2); 41 with type 2 diabetes, 15 with impaired fasting glucose [IFG], and 35 nondiabetic subjects) and 33 lean cases (BMI <25 kg/m(2); 16 type 2 diabetic and 17 nondiabetic subjects). We measured relative beta-cell volume, frequency of beta-cell apoptosis and replication, and new islet formation from exocrine ducts (neogenesis). Relative beta-cell volume was increased in obese versus lean nondiabetic cases (P = 0.05) through the mechanism of increased neogenesis (P < 0.05). Obese humans with IFG and type 2 diabetes had a 40% (P < 0.05) and 63% (P < 0.01) deficit and lean cases of type 2 diabetes had a 41% deficit (P < 0.05) in relative beta-cell volume compared with nondiabetic obese and lean cases, respectively. The frequency of beta-cell replication was very low in all cases and no different among groups. Neogenesis, while increased with obesity, was comparable in obese type 2 diabetic, IFG, or nondiabetic subjects and in lean type 2 diabetic or nondiabetic subjects. However, the frequency of beta-cell apoptosis was increased 10-fold in lean and 3-fold in obese cases of type 2 diabetes compared with their respective nondiabetic control group (P < 0.05). We conclude that beta-cell mass is decreased in type 2 diabetes and that the mechanism underlying this is increased beta-cell apoptosis. Since the major defect leading to a decrease in beta-cell mass in type 2 diabetes is increased apoptosis, while new islet formation and beta-cell replication are normal, therapeutic approaches designed to arrest apoptosis could be a significant new development in the management of type 2 diabetes, because this approach might actually reverse the disease to a degree rather than just palliate glycemia.
Similar articles
-
Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.Diabetes. 2003 Sep;52(9):2304-14. doi: 10.2337/diabetes.52.9.2304. Diabetes. 2003. PMID: 12941770
-
{beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes.Endocrinology. 2010 Apr;151(4):1462-72. doi: 10.1210/en.2009-1277. Epub 2010 Feb 22. Endocrinology. 2010. PMID: 20176718
-
High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.Diabetes. 2007 Aug;56(8):2016-27. doi: 10.2337/db07-0197. Epub 2007 May 2. Diabetes. 2007. PMID: 17475933
-
Distinctions between islet neogenesis and β-cell replication: implications for reversal of Type 1 and 2 diabetes.J Diabetes. 2010 Jun;2(2):76-84. doi: 10.1111/j.1753-0407.2010.00074.x. Epub 2010 Mar 25. J Diabetes. 2010. PMID: 20923488 Review.
-
Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43. doi: 10.1210/jc.2004-0405. J Clin Endocrinol Metab. 2004. PMID: 15292279 Review.
Cited by
-
Associations between time in range and insulin secretory capacity in Japanese patients with type 2 diabetes.Sci Rep. 2024 Jun 5;14(1):12910. doi: 10.1038/s41598-024-63678-5. Sci Rep. 2024. PMID: 38839813 Free PMC article.
-
GRP94 is an IGF-1R chaperone and regulates beta cell death in diabetes.Cell Death Dis. 2024 May 29;15(5):374. doi: 10.1038/s41419-024-06754-y. Cell Death Dis. 2024. PMID: 38811543 Free PMC article.
-
Upregulation of α-ENaC induces pancreatic β-cell dysfunction, ER stress, and SIRT2 degradation.J Biomed Res. 2024 May 21;38(3):241-255. doi: 10.7555/JBR.37.20230128. J Biomed Res. 2024. PMID: 38769731 Free PMC article.
-
Non-esterified fatty acid palmitate facilitates oxidative endoplasmic reticulum stress and apoptosis of β-cells by upregulating ERO-1α expression.Redox Biol. 2024 Jul;73:103170. doi: 10.1016/j.redox.2024.103170. Epub 2024 Apr 27. Redox Biol. 2024. PMID: 38692092 Free PMC article.
-
The Effect of Continuous Positive Airway Pressure (CPAP) Therapy on Serum Caspase-3 Level in Patients with Obstructive Sleep Apnea (OSA).Sleep Breath. 2024 Apr 29. doi: 10.1007/s11325-024-03039-8. Online ahead of print. Sleep Breath. 2024. PMID: 38683249
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical